Insider Profile
Frew, Robin Nicole
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Dec 31, 2023
Most Recent Trade
58
Credibility
Score
100%
Hit Rate
+10.2%
Avg 90d Return
+9.5%
Median 90d Return
16
Evaluated Trades
+17.1%
Best Trade
+0.1%
Worst Trade
Hit rate and returns are based on 16 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Date Company Role Nature Dir. Shares Price Value Score
Dec 31, 2023 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 1,770 — — 46
Dec 31, 2023 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 61 — — 46
Dec 19, 2023 $BNS
Bank of Nova Scotia
— Comp. Grant Buy 31,230 $59.99 $1.9M 46
Dec 19, 2023 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 144 — — 46
Dec 19, 2023 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 7,040 $59.79 $421K 46
Dec 19, 2023 $BNS
Bank of Nova Scotia
— Comp. Grant Buy 12,283 $59.79 $734K 46
Dec 31, 2022 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 48 — — 46
Dec 31, 2022 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 1,004 — — 46
Dec 31, 2021 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 41 — — 46
Dec 31, 2021 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 767 — — 46
Dec 31, 2020 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 224 — — 46
Dec 31, 2020 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 14 — — 46
Dec 15, 2020 $BNS
Bank of Nova Scotia
— Comp. Grant Buy 6,100 $62.40 $381K 46
Dec 15, 2020 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 833 — — 46
Dec 15, 2020 $BNS
Bank of Nova Scotia
— Plan / DRIP Buy 2,953 $62.40 $184K 46
Dec 15, 2020 $BNS
Bank of Nova Scotia
— Comp. Grant Buy 12,428 $68.36 $850K 46
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.